Oral pharmaceutical compositions
AssigneeAssembly Biosciences, Inc.
InventorsZhixin ZONG, Nicole WHITE, Yi WU
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and compositions for treating and/or inhibiting the development or progression of diseases or disorders caused by, or associated with, herpes virus infection. In particular, provided are oral high bioavailability and long-acting pharmaceutical compositions comprising Compound 1; methods for their manufacture; and the use of said pharmaceutical compositions as a medicament and for the treatment of diseases or disorders caused by, or associated with, herpes virus.
Claims22
An oral pharmaceutical composition comprising a solid dispersion, wherein the solid dispersion comprises a compound (Compound 1) represented by:
- or a pharmaceutically acceptable salt thereof, and at least one matrix polymer.
(canceled)
A solid dispersion, wherein the solid dispersion comprises:
- a. Compound 1 or a pharmaceutically acceptable salt thereof;
- b. at least one matrix polymer;
- and
- c. optionally one or more pharmaceutically acceptable excipients.
Dependencies are inferred from the claim text.